Peter Dehlinger is an Intellectual Property partner in King & Spalding’s Silicon Valley office. He has more than 30 years of experience as a patent attorney. His practice encompasses patent procurement and counseling, invalidity and non-infringement opinions, licensing advice, as well as patent and technical support in litigation and interference matters. Involved in patent law before and during the rise of biotechnology, he has particular expertise in the needs of biopharmaceutical companies, and currently represents companies with technologies in molecular biology, pharmaceutical chemistry, drug delivery systems, diagnostics, instrumentation, microfluidics, solid-state devices, and image-guided surgery. Representative clients include, AVI Biopharma, UltraClean Technology Systems, GeneLabs Technologies, Picobella, LP, Helix Biopharma, Dendreon, Nektar Therapeutics, Solexa, Ventria Bioscience, Carbylan, Bioabsorbable Therapeutics and Oraya Therapeutics.
Selected Publications